CLVS, TCOM and GTE among pre market gainers

Axsome Therapeutics (AXSM) +50% as FDA issues proposed labeling for depression drug.
Agile Therapeutics (AGRX) +42%.
Nutex Health (NUTX) +14% to join both Russell 2000 and Russell 3000 indexes.
Femasys (FEMY) +16%.
Siyata Mobile (SYTA) +14% push-to-talk over cellular SD7 device is now commercially available and sold through FirstNet(R) and AT&T Inc.
Priority Technology Holdings (PRTH) +11%.
U.S. Global Investors (GROW) +11% on offer to acquire U.S. Global Investors.
Blackboxstocks (BLBX) +8%.
Virgin Orbit Holdings (VORB) +12% e stablishes new Brazilian subsidiary and receives operator’s license for launch operations in Alcântara.
Accelerate Diagnostics (AXDX) +7%.
Hemisphere Media Group (HMTV) +7%.
Cloopen Group Holding (RAAS) +7%.
Capricor Therapeutics (CAPR) +7% on posting statistically significant data for DMD candidate in open-label trial.
The RealReal (REAL) +7%.
Yatsen Holding (YSG) +6%.
DouYu International Holdings (DOYU) +6%.
Yum China Holdings (YUMC) +6% Mercury fintech added to list of companies facing possible delisting by SEC.
IronNet (IRNT) +6%.
Trip.com Group Limited (TCOM) +6%.
Society Pass (SOPA) +5% t argeted at the digital first southeast asia region.
Vroom (VRM) +5%.
Dare Bioscience (DARE) +4%.
Kingsoft Cloud Holdings (KC) +5%.
Gran Tierra Energy (GTE) +4%.
Clovis Oncology (CLVS) +5%.